Dysplasia Epiphysealis Hemimelica Treatment Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 – 2025
- Transparency Market Research
- February 2036
- 0 pages
Dysplasia epiphysealis hemimelica (DEH), commonly known as Trevor disease, is a rare non-hereditary epiphyseal disorder, which is characterized by localized overgrowth of osteochondral affecting one or more ossification centers or epiphyses. DEH is an asymmetrical and abnormal development of fibrocartilage, including endochondral ossification to cease dysplasia epiphysealis hemimelica once the growth process is completed. The disorder is three times more common in males than females, and most patients are first recognized between the ages of 3 and 15 years. Dysplasia epiphysealis hemimelica mostly arises in the lower limb with the distal tibia, distal femur, distal fibula, talus, tarsal bones, and proximal tibia in the order of the frequency. Dysplasia epiphysealis hemimelica is categorized by osteocartilaginous overgrowth. The disorder primarily targets long bones of the tarsal and lower extremities of bones. The incidence of Trevor disease is 1 case per 1 million population, and the etiology of the disorder is unknown.
The global dysplasia epiphysealis hemimelica treatment market is segmented on the basis of treatment and geography. Based on treatment, the global market is segmented into imaging, radiology, and surgeries. The imaging segment of the dysplasia epiphysealis hemimelica treatment market is categorized into computed tomography (CT) scan, magnetic resonance imaging (MRI), and position emission tomography (PET). The radiology approach normally displays an asymmetrical mass with focal ossification rising from one side of the affected epiphysis. The surgical approach includes hip replacement surgery, knee replacement surgery, and surgical excision of mass with preservation of the joint.
Geographically, the dysplasia epiphysealis hemimelica treatment market is segmented into five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America dominates the global market, followed by Europe. The prime factors which have accentuated the growth of the market in these regions are growing awareness about malignant effects of dysplasia epiphysealis hemimelica among the adult population and availability of sophisticated and technologically advanced treatment options. The Asia Pacific market is projected to expand at a high growth rate during the forecast period owing to factors such as high prevalence of dysplasia epiphysealis hemimelica, high population density in South East Asian countries such as China, Malaysia, and Singapore, and strong government support for improved health care infrastructures. Furthermore, emerging economies and easy market penetration in developing Asian countries are projected to drive the market growth in the near future. In Latin America and Middle East & Africa regions, increasing government investments for better health care facilities are expected to drive the market growth.
Key players operating in the global dysplasia epiphysealis hemimelica treatment market are Zimmer Biomet, AstraZeneca, Genentech, Inc., Pfizer Inc., Johnson & Johnson Services, Inc., Novartis AG, Teva Pharmaceutical Industries, Ltd., and Medacta International.
The report offers a comprehensive evaluation of the market. It does so via in-depth qualitative insights, historical data, and verifiable projections about market size. The projections featured in the report have been derived using proven research methodologies and assumptions. By doing so, the research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology, types, and applications.
The study is a source of reliable data on:
- Market segments and sub-segments
- Market trends and dynamics
- Supply and demand
- Market size
- Current trends/opportunities/challenges
- Competitive landscape
- Technological breakthroughs
- Value chain and stakeholder analysis
The regional analysis covers:
- North America (U.S. and Canada)
- Latin America (Mexico, Brazil, Peru, Chile, and others)
- Western Europe (Germany, U.K., France, Spain, Italy, Nordic countries, Belgium, Netherlands, and Luxembourg)
- Eastern Europe (Poland and Russia)
- Asia Pacific (China, India, Japan, ASEAN, Australia, and New Zealand)
- Middle East and Africa (GCC, Southern Africa, and North Africa)
The report has been compiled through extensive primary research (through interviews, surveys, and observations of seasoned analysts) and secondary research (which entails reputable paid sources, trade journals, and industry body databases). The report also features a complete qualitative and quantitative assessment by analyzing data gathered from industry analysts and market participants across key points in the industry’s value chain.
A separate analysis of prevailing trends in the parent market, macro- and micro-economic indicators, and regulations and mandates is included under the purview of the study. By doing so, the report projects the attractiveness of each major segment over the forecast period.
Highlights of the report:
- A complete backdrop analysis, which includes an assessment of the parent market
- Important changes in market dynamics
- Market segmentation up to the second or third level
- Historical, current, and projected size of the market from the standpoint of both value and volume
- Reporting and evaluation of recent industry developments
- Market shares and strategies of key players
- Emerging niche segments and regional markets
- An objective assessment of the trajectory of the market
- Recommendations to companies for strengthening their foothold in the market
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.
Have query on this report?Make an Enquiry
The team was the biggest help to us. Not only were we provided with customized solutions but also we were guided through the most complicated situations. The information was on-point yet comprehensive. The experience was absolutely satisfying and helped us turn many challenges into opportunities.
Ours is a startup with a unique set of challenges and we were therefore hesitant but the team totally put us at ease with their knowledge and expertise. Our business and its challenges were understood perfectly and help was extended accordingly. The tailor made approach really helped us gain the most informative insights.
The report repository is absolutely impressive –updated and exhaustive in terms of markets covered and information provides. Besides, with the support extended to us by the team, we could reduce costs as well as move to sustainable growth. This really helped us tap into new opportunities. Happy to have gone ahead with ResearchMos.us.
We have had a long term engagement with ResearchMoz.us and never have we felt that the work done and help extended were below flawless. The report repository is one of the best one can hope to tap into. Recently, our partner businesses opted for consultancy services and they are all thrilled with the outcome.
Insights from reports helped us improve our profit margins significantly. Most of the knowledge we needed on the market were provided to us on a granular basis. From trends, and drivers to competitive analysis, the information was not just crisp but also insightful. That helped us chart a robust growth strategy and as of now we are happy to state that we are reaping big benefits.
More from Healthcare
Pharmaceuticals and HealthcareGlobal Bionic Ears Market Professional Survey Report 2017
Pharmaceuticals and HealthcareNeuropsychiatric Disorder Cluster Drug Development Pipeline Review, 2017
Pharmaceuticals and HealthcareHepatitis Drug Development Pipeline Review, 2017